Urgent intubation without neuromuscular blocking agents and the risk of tracheostomy. [PDF]
Fujinaga J +4 more
europepmc +1 more source
EFFECTS OF NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS ON PERIPHERAL AUTONOMIC MECHANISMS IN CATS
R. I. G. Hughes, D.J. CHAPPLE
openalex +1 more source
ABSTRACT Mental fatigue (MF) has been widely investigated in resistance exercise (RE). However, the results remain inconsistent, likely due to variability in the cognitive load across studies and, most importantly, the lack of individualized assessments of self‐reported MF levels among participants before initiating the RE session.
José Luiz Frota Solon Júnior +4 more
wiley +1 more source
Comparative outcomes of corticosteroids, neuromuscular blocking agents, and inhaled nitric oxide in ARDS: a systematic review and network meta-analysis. [PDF]
Xu Z, Liu X, Zhang L, Yan X.
europepmc +1 more source
Peripheral Nerves in Cancer: Regulatory Roles and Therapeutic Strategies
The interaction between cancer cells and peripheral nerves: (1) tumor cells could induce the growth of new neural axons and constructing a neural fiber network within the tumor tissue through secreting nerve growth factors; (2) nerve‐derived bioactive molecules can induce perineural invasion of tumor and regulate the malignant phenotype of tumor, such ...
Yan Fu +6 more
wiley +1 more source
Avoidance versus use of neuromuscular blocking agents for optimizing video laryngoscopy-assisted tracheal intubation: A protocol for a systematic review with meta-analysis and trial sequential analysis. [PDF]
Creutzburg A +7 more
europepmc +1 more source
Effects of neuromuscular blocking agents on the clinical performance of i-gel® and surgical condition in elderly patients undergoing hand surgery: a prospective randomized controlled trial. [PDF]
Cho CK, Change M, Lee SJ, Sung TY.
europepmc +1 more source
Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials [PDF]
Ary Serpa Neto +4 more
openalex +1 more source
Exploring Pembrolizumab‐Induced IM3OS in a Patient With Bladder Cancer
ABSTRACT Pembrolizumab, an immune checkpoint inhibitor (ICI), has transformed cancer treatment across various malignancies, including metastatic urothelial cancer. As the use of pembrolizumab becomes increasingly widespread, understanding its potential adverse effects is essential.
Ching‐Cheng Chan +3 more
wiley +1 more source

